Agile Therapeutics Inc.

NASDAQ: AGRX · Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM

Agile Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.29 -0.19 -0.02
PEG Ratio
0.00 0.00 -0.00
PS Ratio
0.21 0.45 0.29
PB Ratio
-0.26 -0.88 0.13
P/FCF Ratio
-0.44 -0.14 -0.02
P/OCF Ratio
-0.44 -0.14 -0.02
OCF/S Ratio
-0.49 -3.3 -15.9
Debt / Equity Ratio
-0.13 -0.4 1.92
Quick Ratio
0.33 0.75 0.78
Current Ratio
0.46 0.85 0.82
Asset Turnover
1.91 0.76 0.10
Interest Coverage
-14.01 -13.23 -18.14
Return on Equity
0.89 4.58 -8.26
Return on Assets
-1.41 -1.78 -1.95
Return on Invested Capital
2.35 -11.99 -2.67
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.54 0.37 -1.61
Net Profit Margin
-0.74 -2.33 -18.67
Pretax Profit Margin
-0.74 -2.76 -18.26
Operating Profit Margin
-1.01 -3.81 -17.31
FCF Margin
n/a n/a n/a
EBITDA Margin
-1.01 -3.67 -15.83